Stock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech

Stock Track

May 18

METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.

The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1166687213"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166687213\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166687213?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 13:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166687213","market":"nz","top_or_hot":-1,"title":"Stock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech","media":"Stock Track","content":"<p>METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.</p><p>The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-18 13:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.</p><p>The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1166687213","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166687213","pubTimestamp":1779082076,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.The surge appears to be driven by the company's announcement of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"个股追踪|宣布与Sandstone Biotech达成战略合作伙伴关系METIS TECHBIO-P盘中大涨5.53%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}